Skip to main content
Lambert initiative researchers in the lab
News_

News archive

Read all the news stories from the Lambert Initiative

From trialling medicinal cannabis in the treatment of paediatric epilepsy and cancer to a donation that has put Australia at the forefront of medicinal cannabis research, read all the latest news from the Lambert Initiative. 

More News

12 September 2019

Study casts doubt on accuracy of mobile drug testing devices

Research at the University of Sydney Lambert Initiative for Cannabinoid Therapeutics suggests the devices currently used return both false positives and false negatives.
16 July 2019

Cannabis treatment counters addiction: first study of its kind

A Sydney-led study published in a JAMA journal provides the first strong evidence that medicinal cannabis could reduce the rate of relapse for users of cannabis - a leading cause of drug treatment episodes in Australia.
07 May 2019

The science of cannabis and driving

As medical cannabis becomes more readily available, it is imperative that any risks relating to driving are clarified via thorough research.
18 April 2019

Cannabis use in inflammatory bowel disease: new surveys announced

Two new surveys announced for patients using or considering using medicinal cannabis to ease the symptoms of inflammatory bowel disease and for specialists caring for these patients.
27 March 2019

Can medicinal cannabis treat the tics in Tourette syndrome?

A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with Tourette syndrome will be conducted by Wesley Medical Research, with the cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney.
30 January 2019

INSPIRED! $1 billion philanthropic achievement

The University of Sydney has reached its $1 billion target following an epic philanthropic campaign - the most successful of any university in the nation.
12 November 2018

Few doctors prescribe medical cannabis for chemo-induced nausea

Few doctors are prescribing medical cannabis to treat nausea and vomiting caused by chemotherapy because good evidence is lacking, say experts in today's Medical Journal of Australia.
05 September 2018

Cannabis As Medicine Survey CAMS:18 launches

The University of Sydney is launching CAMS:18 - an online survey for people who have used medicinal cannabis in the past 12 months. This survey will provide an 'after' snapshot since legislative changes in 2016.
14 August 2018

Illicit cannabis used for pain, mental health, sleep conditions

Australians who used illicit cannabis for medical reasons did so mainly to treat chronic pain, mental health, sleep and neurological conditions like epilepsy or seizure disorders, according to University of Sydney research.
05 July 2018

Content of illicit cannabis to treat kids with epilepsy revealed

A study of community use of medicinal cannabis to treat childhood epilepsy has found most samples contained some THC and little CBD, contrary to parents' expectations, and a majority were reported as reducing seizures.
04 July 2018

Australian GPs cautiously supportive of medicinal cannabis access

A majority of GPs believe medicinal cannabis should be available on prescription, bypassing the specialist system, but most lack information about how to negotiate the bureaucratic processes to meet increasing patient demand.
20 September 2017

Psychopharmacology professor unlearns cannabis use

Professor Iain McGregor explains how unlearning has led to a new way of seeing the world - from tennis to the perception of failure.

03 May 2017

Cannabinoid researchers join forces

The University of Sydney and Thomas Jefferson University have officially agreed to collaborate on education and research on the therapeutic uses of cannabinoids. 

10 March 2017

Survey reveals cannabis use in Australians with epilepsy

Australians with epilepsy are turning to cannabis products when antiepileptic drug side-effects are intolerable and epilepsy uncontrolled.

18 August 2016

Pioneering study of cannabis extracts in treating epileptic kids

A pioneering study, the Paediatric Epilepsy Lambert Initiative Cannabinoid Analysis (PELICAN), launches today not only to identify issues facing families living with epilepsy but also to analyse cannabis products being used in the community - with the potential to uncover new and more effective medications.

29 March 2016

Legalising medicinal cannabis would create $100 million industry

Analysis from the University of Sydney Business School has found that legalising medicinal cannabis in Australia could create a new industry worth more than $100 million per year. 

26 February 2016

University partners in medical cannabis trial for chemotherapy patients

A clinical trial using a new form of cannabis developed by the University of Sydney’s Lambert Initiative will assess the use of the drug to prevent nausea and vomiting in people undergoing chemotherapy.

12 June 2015

Lambert donation puts Australia at forefront of medicinal cannabinoid research

A $33.7 million gift to the University of Sydney, the largest donation ever made to research, will establish the Lambert Initiative for cannabinoid therapeutics research.